The CR1 gene, implicated in complement activation, is believed to exert its role to AD pathogenesis through amyloid-β clearance, neuroinflammation and tauopathy (the deposition of abnormal tau protein in the brain)64. The gene discussed is MAPT; the disease is Alzheimer disease.